Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Biotech Industry Analysis

UpdatedApr 02, 2026
DataAggregated Company Financials
Companies49
  • 7D6.3%
  • 3M11.0%
  • 1Y19.9%
  • YTDn/a

Over the last 7 days, the Biotech industry has risen 5.9%, driven by gains from Swedish Orphan Biovitrum of 7.2%. In the same time, Diamyd Medical was down 90%. This takes the industry's 12 month performance to a gain of 14%. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Swedish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Apr 2026SEK 233.2bSEK 38.5b-SEK 5,656,500,407.8318.6x-41.2x6.1x
Sat, 28 Feb 2026SEK 225.6bSEK 38.5b-SEK 5,647,780,520.9017.9x-40x5.9x
Mon, 26 Jan 2026SEK 230.8bSEK 65.8bSEK 1.1b37.2x206.9x3.5x
Wed, 24 Dec 2025SEK 206.9bSEK 38.1b-SEK 556,461,769.0032.8x-371.8x5.4x
Fri, 21 Nov 2025SEK 203.6bSEK 37.7b-SEK 932,687,682.2632.4x-218.3x5.4x
Sun, 19 Oct 2025SEK 204.6bSEK 36.4bSEK 3.1b30.9x66.1x5.6x
Tue, 16 Sep 2025SEK 190.8bSEK 36.4bSEK 3.0b29.3x63x5.2x
Thu, 14 Aug 2025SEK 188.5bSEK 35.9bSEK 2.8b28.1x67.6x5.2x
Sat, 12 Jul 2025SEK 190.8bSEK 35.2bSEK 2.3b30.2x83x5.4x
Mon, 09 Jun 2025SEK 195.8bSEK 35.2bSEK 2.2b30.2x88.4x5.6x
Wed, 07 May 2025SEK 191.5bSEK 34.0bSEK 836.4m29.9x229x5.6x
Fri, 04 Apr 2025SEK 183.9bSEK 33.7bSEK 722.2m31.2x254.7x5.5x
Sun, 02 Mar 2025SEK 214.7bSEK 33.3bSEK 447.3m43.9x479.9x6.4x
Tue, 28 Jan 2025SEK 222.3bSEK 33.1b-SEK 4,401,378,149.25141.1x-50.5x6.7x
Thu, 26 Dec 2024SEK 215.8bSEK 33.0b-SEK 4,423,381,961.77157.1x-48.8x6.5x
Sat, 23 Nov 2024SEK 206.0bSEK 33.1b-SEK 4,544,960,916.32146.7x-45.3x6.2x
Mon, 21 Oct 2024SEK 214.8bSEK 31.4b-SEK 5,525,592,696.7551x-38.9x6.8x
Wed, 18 Sep 2024SEK 219.8bSEK 31.5b-SEK 5,518,104,428.0453.1x-39.8x7x
Fri, 16 Aug 2024SEK 205.6bSEK 31.4b-SEK 5,422,662,765.6848.7x-37.9x6.6x
Sun, 14 Jul 2024SEK 200.8bSEK 30.6b-SEK 5,498,896,467.8039.6x-36.5x6.6x
Tue, 11 Jun 2024SEK 196.5bSEK 30.6b-SEK 5,436,121,775.5838.6x-36.2x6.4x
Thu, 09 May 2024SEK 186.6bSEK 31.0b-SEK 5,260,034,088.1551x-35.5x6x
Sat, 06 Apr 2024SEK 181.4bSEK 29.8b-SEK 5,279,211,965.1161.5x-34.4x6.1x
Mon, 04 Mar 2024SEK 179.3bSEK 29.8b-SEK 5,621,314,313.8151.9x-31.9x6x
Wed, 31 Jan 2024SEK 327.4bSEK 28.7b-SEK 1,193,160,809.0060.4x-274.4x11.4x
Fri, 29 Dec 2023SEK 184.5bSEK 28.7b-SEK 1,196,011,337.0061.4x-154.2x6.4x
Sun, 26 Nov 2023SEK 172.5bSEK 28.7b-SEK 1,155,963,055.0054.2x-149.3x6x
Tue, 24 Oct 2023SEK 151.2bSEK 27.4b-SEK 1,985,474,971.0048.5x-76.1x5.5x
Thu, 21 Sep 2023SEK 164.1bSEK 27.4b-SEK 2,020,934,417.0051.6x-81.2x6x
Sat, 19 Aug 2023SEK 152.1bSEK 27.6b-SEK 1,582,721,433.0053.5x-96.1x5.5x
Mon, 17 Jul 2023SEK 153.9bSEK 26.5b-SEK 1,385,021,170.0046.2x-111.1x5.8x
Wed, 14 Jun 2023SEK 172.2bSEK 26.4b-SEK 1,256,068,844.0045.9x-137.1x6.5x
Fri, 12 May 2023SEK 173.9bSEK 26.4b-SEK 1,361,605,258.0046.1x-127.7x6.6x
Sun, 09 Apr 2023SEK 171.3bSEK 25.4b-SEK 2,037,029,771.0038.4x-84.1x6.7x
Price to Earnings Ratio

-84.1x


Total Market Cap: SEK 171.3bTotal Earnings: -SEK 2,037,029,771.00Total Revenue: SEK 25.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Biotech Industry Price to Earnings3Y Average -47.8x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swedish Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 6.0x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Biotech compare with similar industries?

SE Market2.73%
Healthcare6.32%
Biotech6.26%
Biotech6.26%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SOBI Swedish Orphan BiovitrumSEK 400.804.6%
+SEK 6.2b		42.7%PE289.8x
BONEX Bonesupport HoldingSEK 214.2013.8%
+SEK 1.7b		-32.3%PE100.6x
BIOA B BioArcticSEK 327.403.2%
+SEK 904.9m		86.6%PE28.4x
HNSA Hansa BiopharmaSEK 32.686.8%
+SEK 211.7m		44.3%PS15x
SANION SanionaSEK 16.365.1%
+SEK 110.4m		165.2%PE7.9x

Latest News

CRNO B
SEK 6.49
Cereno Scientific
7D
-2.6%
1Y
8.5%
ACTI
SEK 0.07
Active Biotech
7D
57.6%
1Y
-9.7%
BONEX
SEK 214.20
Bonesupport Holding
7D
13.8%
1Y
-32.3%
HNSA
SEK 32.68
Hansa Biopharma
7D
6.8%
1Y
44.3%
SOBI
SEK 400.80
Swedish Orphan Biovitrum
7D
4.6%
1Y
42.7%
ONCO
SEK 1.40
Oncopeptides
7D
-4.5%
1Y
-17.9%
DMYD B
SEK 1.42
Diamyd Medical
7D
-90.2%
1Y
-83.2%
EGTX
SEK 5.90
Egetis Therapeutics
7D
3.5%
1Y
37.0%
BIOA B
SEK 327.40
BioArctic
7D
3.2%
1Y
86.6%
IMMU
SEK 4.44
Mendus
7D
-9.4%
1Y
-20.1%

We Think Mendus (STO:IMMU) Can Afford To Drive Business Growth

Mar 27
We Think Mendus (STO:IMMU) Can Afford To Drive Business Growth
MVIR
SEK 2.35
Medivir
7D
-3.9%
1Y
83.9%

Rare Disease And Liver Cancer Pipeline Will Transform Long Term Prospects

Catalysts About Medivir Medivir is a biotech company focused on developing first in class therapies in oncology and rare bone diseases, alongside partnered programs in animal health. What are the underlying business or industry changes driving this perspective?
CURAS
DKK 14.15
Curasight
7D
-10.2%
1Y
77.8%
CANTA
SEK 4.03
Cantargia
7D
-2.1%
1Y
204.8%
SANION
SEK 16.36
Saniona
7D
5.1%
1Y
165.2%
DEX
SEK 7.15
Dextech Medical
7D
-10.6%
1Y
68.6%
HAMLET B
SEK 4.20
Hamlet BioPharma
7D
14.3%
1Y
1.4%